AZI vs BABA

The company exhibits severe financial distress with a Piotroski F-Score of 3/9, indicating weak financial health. Despite a high revenue growth rate of 65.90%, profitability is deeply negative, with an ROA of -45.76% and negative margins across all key metrics. The stock trades at a fraction of its $140.84 intrinsic value estimate, but this reflects extreme risk rather than undervaluation, as balance sheet weaknesses and lack of analyst coverage suggest high uncertainty. Technical indicators and insider sentiment are also bearish, reinforcing the deteriorating fundamentals.

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.